tiprankstipranks
Trending News
More News >
Abbott Laboratories (ABT)
NYSE:ABT
US Market

Abbott Laboratories (ABT) Ratios

Compare
8,352 Followers

Abbott Laboratories Ratios

ABT's free cash flow for Q4 2024 was $0.55. For the 2024 fiscal year, ABT's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.67 1.64 1.63 1.85 1.72
Quick Ratio
1.23 1.16 1.23 1.46 1.30
Cash Ratio
0.54 0.50 0.64 0.75 0.57
Solvency Ratio
0.50 0.26 0.27 0.27 0.20
Operating Cash Flow Ratio
0.60 0.52 0.62 0.80 0.66
Short-Term Operating Cash Flow Coverage
5.71 6.72 4.26 13.97 35.91
Net Current Asset Value
$ -9.86B$ -11.72B$ -12.31B$ -14.93B$ -19.10B
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.22 0.24 0.25 0.27
Debt-to-Equity Ratio
0.32 0.41 0.48 0.53 0.60
Debt-to-Capital Ratio
0.24 0.29 0.33 0.35 0.37
Long-Term Debt-to-Capital Ratio
0.21 0.26 0.28 0.33 0.36
Financial Leverage Ratio
1.71 1.90 2.03 2.10 2.21
Debt Service Coverage Ratio
8.36 5.63 4.19 9.33 11.52
Interest Coverage Ratio
12.21 10.17 22.30 17.19 10.71
Debt to Market Cap
0.07 0.08 0.09 0.07 0.10
Interest Debt Per Share
9.00 9.52 10.32 10.98 11.36
Net Debt to EBITDA
0.68 0.85 0.63 0.72 1.46
Profitability Margins
Gross Profit Margin
55.41%55.18%56.15%56.97%56.65%
EBIT Margin
18.05%18.20%20.31%20.30%15.93%
EBITDA Margin
25.83%26.44%28.36%29.58%25.40%
Operating Profit Margin
16.27%16.15%19.16%19.56%15.48%
Pretax Profit Margin
16.72%16.61%19.03%19.06%14.36%
Net Profit Margin
31.95%14.27%15.88%16.42%12.99%
Continuous Operations Profit Margin
31.95%14.27%15.88%16.42%12.92%
Net Income Per EBT
191.10%85.88%83.47%86.12%90.48%
EBT Per EBIT
102.75%102.87%99.33%97.46%92.74%
Return on Assets (ROA)
16.46%7.82%9.31%9.40%6.20%
Return on Equity (ROE)
28.12%14.83%18.90%19.75%13.71%
Return on Capital Employed (ROCE)
10.15%10.91%14.19%13.57%8.83%
Return on Invested Capital (ROIC)
18.97%9.17%11.36%11.50%7.89%
Return on Tangible Assets
25.94%14.05%16.83%18.03%13.21%
Earnings Yield
6.84%3.00%3.60%2.83%2.32%
Efficiency Ratios
Receivables Turnover
4.42 6.11 7.02 6.64 5.40
Payables Turnover
4.46 4.19 4.15 4.21 3.80
Inventory Turnover
3.02 2.74 3.10 3.59 2.99
Fixed Asset Turnover
3.94 3.56 4.76 4.81 3.83
Asset Turnover
0.52 0.55 0.59 0.57 0.48
Working Capital Turnover Ratio
4.58 4.32 4.18 4.38 5.19
Cash Conversion Cycle
121.62 105.94 81.85 69.72 93.58
Days of Sales Outstanding
82.61 59.74 51.99 54.97 67.65
Days of Inventory Outstanding
120.86 133.41 117.71 101.54 121.93
Days of Payables Outstanding
81.85 87.21 87.85 86.80 96.00
Operating Cycle
203.47 193.15 169.70 156.51 189.58
Cash Flow Ratios
Operating Cash Flow Per Share
4.94 4.19 5.47 5.93 4.46
Free Cash Flow Per Share
3.67 2.92 4.45 4.87 3.23
CapEx Per Share
1.27 1.27 1.01 1.06 1.23
Free Cash Flow to Operating Cash Flow
0.74 0.70 0.81 0.82 0.72
Dividend Paid and CapEx Coverage Ratio
1.42 1.26 1.88 2.07 1.67
Capital Expenditure Coverage Ratio
3.88 3.30 5.39 5.59 3.63
Operating Cash Flow Coverage Ratio
0.57 0.46 0.54 0.55 0.40
Operating Cash Flow to Sales Ratio
0.20 0.18 0.22 0.24 0.23
Free Cash Flow Yield
3.24%2.65%4.05%3.46%2.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.62 33.35 27.76 35.33 43.19
Price-to-Sales (P/S) Ratio
4.67 4.76 4.41 5.80 5.61
Price-to-Book (P/B) Ratio
4.11 4.94 5.25 6.98 5.92
Price-to-Free Cash Flow (P/FCF) Ratio
30.84 37.73 24.66 28.89 33.91
Price-to-Operating Cash Flow Ratio
22.89 26.29 20.09 23.72 24.57
Price-to-Earnings Growth (PEG) Ratio
0.11 -2.05 -36.74 0.61 1.99
Price-to-Fair Value
4.11 4.94 5.25 6.98 5.92
Enterprise Value Multiple
18.76 18.84 16.18 20.33 23.54
EV to EBITDA
18.76 18.84 16.18 20.33 23.54
EV to Sales
4.85 4.98 4.59 6.01 5.98
EV to Free Cash Flow
32.01 39.50 25.67 29.95 36.15
EV to Operating Cash Flow
23.75 27.52 20.91 24.59 26.19
Tangible Book Value Per Share
10.48 3.65 2.08 0.03 -3.12
Shareholders’ Equity Per Share
27.52 22.26 20.93 20.17 18.49
Tax and Other Ratios
Effective Tax Rate
-0.91 0.14 0.17 0.14 0.10
Revenue Per Share
24.22 23.13 24.90 24.27 19.52
Net Income Per Share
7.74 3.30 3.95 3.98 2.54
Tax Burden
1.91 0.86 0.83 0.86 0.90
Interest Burden
0.93 0.91 0.94 0.94 0.90
Research & Development to Revenue
0.07 0.07 0.07 0.06 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.02
Income Quality
0.64 1.27 1.38 1.49 1.76
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis